tetano
Editor, Senior Moderator
Eur Rev Med Pharmacol Sci
. 2021 May;25(9):3607-3609.
doi: 10.26355/eurrev_202105_25843.
Prevalence and significance of mediastinal lymphadenopathy in patients with Severe Acute Respiratory Syndrome Corona Virus-2 infection
F Sampsonas[SUP] 1 [/SUP], M Lagadinou, T Karampitsakos, E Solomou, M Doulberis, M Marangos, A Tzouvelekis
Affiliations
Abstract
Severe Acute Respiratory Syndrome Corona Virus-2 is the causative factor of Coronavirus Disease 2019. Early in the pandemic, mediastinal lymphadenopathy was not considered to be a significant radiologic finding of the SARS-COV-2 disease. Nevertheless, most recent studies associate mediastinal lymphadenopathy with more severe COVID-19 disease and poorer patient outcomes.
. 2021 May;25(9):3607-3609.
doi: 10.26355/eurrev_202105_25843.
Prevalence and significance of mediastinal lymphadenopathy in patients with Severe Acute Respiratory Syndrome Corona Virus-2 infection
F Sampsonas[SUP] 1 [/SUP], M Lagadinou, T Karampitsakos, E Solomou, M Doulberis, M Marangos, A Tzouvelekis
Affiliations
- PMID: 34002835
- DOI: 10.26355/eurrev_202105_25843
Abstract
Severe Acute Respiratory Syndrome Corona Virus-2 is the causative factor of Coronavirus Disease 2019. Early in the pandemic, mediastinal lymphadenopathy was not considered to be a significant radiologic finding of the SARS-COV-2 disease. Nevertheless, most recent studies associate mediastinal lymphadenopathy with more severe COVID-19 disease and poorer patient outcomes.